Table 1.
OM (n = 60) | Non-OM (n = 79) | p-value | |
---|---|---|---|
MRSA, n (%) | 9 (15.0) | 19 (24.1) | 0.19 |
SCCmec type of MRSA | |||
Type I, n (%) | 2 (3.3) | 12 (15.2) | 0.11 |
Type IV, n (%) | 7 (11.7) | 6 (7.6) | 0.060 |
Type V, n (%) | 0 (0) | 1 (1.3) | 0.68 |
MLST | |||
Predominant type (n, %) | ST188 (11,18.3), ST59 (9, 15.0) | ST188 (15,19.0), ST59 (13, 16.5) | 0.92, 0.82 |
New type (n) | ST3538 (1) | ST3539 (1) | |
spa typing | |||
Predominant type (n, %) | t189 (10,16.7), t437 (8, 13.3) | t189 (14, 17.7), t437 (12, 15.2) | 0.87, 0.76 |
New type (n) | t16342 (1), t16519 (1), and t16520 (1) | t16521 (1) | |
agr grouping (n, %) | |||
Predominant group | agr I (38, 63.3) | agr I (62, 78.5) | 0.049 |
agr III/IV | 18 (30.0) | 8 (10.1) | 0.0029 |
Predominant clone (n, %) | ST188-t189-agr I (10, 16.7) | ST188-t189-agr I (13, 16.5) | 0.97 |
ST59-t437-agr I (8,13.3) | ST59-t437-agr I (11, 13.9) | 0.92 | |
Significant differences are in boldface.